Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04237649
Title KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN

Facility Status City State Zip Country Details
University Of California LA Los Angeles California 90095 United States Details
Yale University Yale Cancer Center New Haven Connecticut 06511 United States Details
Northwestern University Med School Chicago Illinois 60611 United States Details
WA Uni School Of Med Dept. of Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Uni of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Shatin New Territories Hong Kong Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Sunto Gun Shizuoka 411 8777 Japan Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field